ERN1 and Miyoshi myopathy: IRE1α has been shown to promote the malignant growth of MM cells by facilitating adaptation to chronic ER stress through enhanced ER‐associated degradation capabilities.[38] The strong dependency of MM cells on IRE1α/XBP1s signaling underscores this pathway as a vulnerability for the clinical treatment of MM.